Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA skin rash while taking Wegovy can be unsettling, but most reactions people notice are mild and short-lived. Semaglutide, the medicine in Wegovy, can occasionally cause skin changes — from localised redness at the injection site to itching that appears elsewhere on the body. These are recognised in the clinical profile of GLP-1 medicines. Wegovy is a prescription-only medicine, so any new or worsening skin symptom is worth discussing with the prescriber who oversees your treatment rather than managing it alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works by activating GLP-1 receptors involved in appetite regulation, but the immune and skin systems can respond to any subcutaneous injection — or to the medicine itself. The most straightforward explanation for skin reactions at the injection site is localised trauma and the body's inflammatory response to a foreign substance being introduced under the skin. This is not unique to semaglutide; it is common to many injectable treatments.
Beyond the injection site, some people notice itching, hives, or a rash that appears elsewhere on the body. The NHS patient information on semaglutide lists skin reactions among the recognised side effects of the medicine, and the product's Summary of Product Characteristics lists hypersensitivity reactions as a known but uncommon occurrence. This means they are documented and real, but they affect fewer than one person in a hundred at that level of severity.
Most mild injection-site redness or itching at the needle site does not mean you have an allergy. Rotating your injection site (abdomen, thigh or upper arm) each week helps reduce localised irritation. Allowing the pen to reach room temperature before injecting and pressing gently on the area afterwards can also make a difference. For anything beyond minor localised redness, speaking with your prescriber gives you a clearer picture of what is happening.
The redness, warmth or mild swelling that can appear after a Wegovy injection typically stays within a few centimetres of the needle site. It usually peaks within an hour and fades within twenty-four to forty-eight hours. Mild bruising is also possible if a small blood vessel is nicked during the injection, this is harmless and resolves on its own.
Itching directly at the site is common. Some people describe a raised, slightly firm patch (a small wheal) that disappears without treatment. These are considered injection-site reactions rather than a systemic response to semaglutide, and they are rarely a reason to stop treatment.
If you find reactions are recurring at the same spot, the most practical fix is stricter rotation. A fuller overview of Wegovy's side effect profile puts skin reactions in context alongside the gastrointestinal effects that tend to attract more attention. Needle length and angle can also matter; the Patient Information Leaflet that comes with your pen covers the recommended technique in detail.
The distinction that matters most is between a localised injection-site reaction and a systemic or allergic response. A rash that spreads beyond the injection site, appears on the trunk or face, or is accompanied by swelling, fever, or difficulty breathing is a different matter entirely.
The NHS semaglutide guidance lists signs of a serious allergic reaction as a medical emergency: swelling of the face, lips, tongue or throat, severe rash covering a large area, dizziness and rapid heartbeat. If any of these develop, stop the injection and call 999 or go to your nearest A&E. Do not wait to see if it settles.
Less urgent but still worth prompt prescriber contact: a new rash that appears and persists for more than a day or two away from the injection site, any rash that is spreading, or itching that is disturbing your sleep or daily life. These may or may not be related to Wegovy, but ruling out other causes is straightforward and reassuring. A question our prescribers hear fairly regularly is whether a rash that appeared weeks into treatment can still be drug-related, the answer is yes, hypersensitivity reactions can emerge at any point, not just at the start.
Any suspected side effect can be reported to the MHRA's Yellow Card scheme. You do not need to be certain it is caused by the medicine, a suspicion is enough to make a report, and that data shapes how regulators monitor these medicines over time.
Before any treatment begins, a GPhC-registered Independent Prescriber at our pharmacy reads through your full health history, including any known allergies or previous skin reactions to medicines or injections. Skin conditions or hypersensitivity history can influence whether semaglutide is appropriate for you, what starting approach makes sense, and what to watch for. If you want a closer look at what has been reported, our guides covering Wegovy side effects on the skin and the range of semaglutide skin side effects more broadly set out the detail in one place.
That review happens the same day you submit your consultation, a real clinician reads your answers, not a decision engine. If you have already started Wegovy and developed a skin reaction you are not sure about, reaching our team through aftercare is the right step. We offer support seven days a week, and a prescriber can advise you on whether to continue, pause or stop while you are assessed.
It is worth knowing that semaglutide (the active ingredient in Wegovy) has a broader side-effect profile than skin reactions alone. If you are finding the injection itself difficult to manage, the full Wegovy overview covers storage, administration and what the titration schedule involves. For people who prefer to avoid injections altogether, oral options are now available; our treatment overview outlines what is currently licensed in the UK.
If you are still deciding whether Wegovy is right for you, a free consultation with our prescribers is the place to start, suitability, side effects and your personal medical history are all part of the conversation. People who experience persistent itchy skin as a semaglutide side effect often find it helpful to raise this early, and a page on whether sensitive skin is a recognised side effect of Wegovy can help frame that conversation with your prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.